Skip to main content

20-06-2017 | Non-small-cell lung cancer | Interview | Video

Lung cancer highlights from John Heymach

ASCO expert John Heymach reviews the key lung cancer trial findings presented at the ASCO 2017 annual meeting.

Enriched treatment pathway for non-driver NSCLC

What is it and why do I need it?

Have your say on Medicine Matters

Visit the conference hub

Image Credits